The QHNCC is investigating pharmaceutical interventions for chronic inflammation, through screening bioactive extracts, as well as deriving new pharmaceutical delivery systems.

  • ResearchDSC_0326_2_web_large
    • High throughput screening of bioactive extracts for anti-inflammatory properties
    • Development of an in-situ nasal gelling drug delivery system for the treatment of chronic rhinosinusitis
    • Comparing the sensory attributes and patient preference of Cophenylcaine Forte and CoPhenylcaine Zest Nasal Spray.
  • Collaborations
    • Princess Alexandra Hospital
    • Pharmacy Australia Centre of Excellence (PACE)
  • Key Personnel
    • Prof Ben Panizza
    • A/Prof Ben Wallwork
    • A/Prof Peter Cabot
    • Dr Harendra (Harry) Parekh.